Air-Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations
- PMID: 32953944
- PMCID: PMC7500038
- DOI: 10.1089/aivt.2017.0034
Air-Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations
Abstract
In vitro air-liquid interface (ALI) cell culture models can potentially be used to assess inhalation toxicology endpoints and are usually considered, in terms of relevancy, between classic (i.e., submerged) in vitro models and animal-based models. In some situations that need to be clearly defined, ALI methods may represent a complement or an alternative option to in vivo experimentations or classic in vitro methods. However, it is clear that many different approaches exist and that only very limited validation studies have been carried out to date. This means comparison of data from different methods is difficult and available methods are currently not suitable for use in regulatory assessments. This is despite inhalation toxicology being a priority area for many governmental organizations. In this setting, a 1-day workshop on ALI in vitro models for respiratory toxicology research was organized in Paris in March 2016 to assess the situation and to discuss what might be possible in terms of validation studies. The workshop was attended by major parties in Europe and brought together more than 60 representatives from various academic, commercial, and regulatory organizations. Following plenary, oral, and poster presentations, an expert panel was convened to lead a discussion on possible approaches to validation studies for ALI inhalation models. A series of recommendations were made and the outcomes of the workshop are reported.
Keywords: air–liquid interface; in vitro; inhalation; lung cell models; toxicology; validation.
© Ghislaine Lacroix et al., 2018; Published by Mary Ann Liebert, Inc.
Conflict of interest statement
The authors reported no competing financial interests.
Figures




Similar articles
-
Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.Inhal Toxicol. 2007 Jun;19(8):631-43. doi: 10.1080/08958370701353080. Inhal Toxicol. 2007. PMID: 17510836
-
Air-liquid interface (ALI) impact on different respiratory cell cultures.Eur J Pharm Biopharm. 2023 Mar;184:62-82. doi: 10.1016/j.ejpb.2023.01.013. Epub 2023 Jan 22. Eur J Pharm Biopharm. 2023. PMID: 36696943 Review.
-
Approaches to evaluating the toxicity and carcinogenicity of man-made fibers: summary of a workshop held November 11-13, 1991, Durham, North Carolina.Regul Toxicol Pharmacol. 1992 Dec;16(3):321-64. doi: 10.1016/0273-2300(92)90011-w. Regul Toxicol Pharmacol. 1992. PMID: 1293648 Review.
-
A novel exposure system generating nebulized aerosol of sulfur mustard in comparison to the standard submerse exposure.Chem Biol Interact. 2019 Jan 25;298:121-128. doi: 10.1016/j.cbi.2018.11.025. Epub 2018 Nov 28. Chem Biol Interact. 2019. PMID: 30502332
-
In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection.Toxicol In Vitro. 2020 Mar;63:104714. doi: 10.1016/j.tiv.2019.104714. Epub 2019 Nov 6. Toxicol In Vitro. 2020. PMID: 31706036
Cited by
-
Advanced lung organoids for respiratory system and pulmonary disease modeling.J Tissue Eng. 2024 Feb 22;15:20417314241232502. doi: 10.1177/20417314241232502. eCollection 2024 Jan-Dec. J Tissue Eng. 2024. PMID: 38406820 Free PMC article. Review.
-
Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery.Polymers (Basel). 2023 Jan 7;15(2):318. doi: 10.3390/polym15020318. Polymers (Basel). 2023. PMID: 36679199 Free PMC article. Review.
-
Human in vitro blood barrier models: architectures and applications.Tissue Barriers. 2024 Apr 2;12(2):2222628. doi: 10.1080/21688370.2023.2222628. Epub 2023 Jun 20. Tissue Barriers. 2024. PMID: 37339009 Free PMC article. Review.
-
New approach methodologies to enhance human health risk assessment of immunotoxic properties of chemicals - a PARC (Partnership for the Assessment of Risk from Chemicals) project.Front Toxicol. 2024 Apr 9;6:1339104. doi: 10.3389/ftox.2024.1339104. eCollection 2024. Front Toxicol. 2024. PMID: 38654939 Free PMC article. Review.
-
Parametric Optimization of an Air-Liquid Interface System for Flow-Through Inhalation Exposure to Nanoparticles: Assessing Dosimetry and Intracellular Uptake of CeO2 Nanoparticles.Nanomaterials (Basel). 2020 Nov 28;10(12):2369. doi: 10.3390/nano10122369. Nanomaterials (Basel). 2020. PMID: 33260672 Free PMC article.
References
-
- Paur HR, Mülhopt S, Weiss C, et al. . In vitro exposure systems and bioassays for the assessment of toxicity of nanoparticles to the human lung. J Verbrauch Lebensm 2008:3;319–329
-
- Paur H-R, Cassee FR, Teeguarden J, et al. . In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung—A dialog between aerosol science and biology. J Aerosol Sci 2011:42;668–692
-
- Landsiedel R, Sauer UG, Ma-Hock L, et al. . Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine (Lond) 2014:9;2557–2585 - PubMed
-
- WHO. Ambient air pollution: a global assessments of exposure and burden of disease. http://apps.who.int/iris/bitstream/10665/250141/1/9789241511353-eng.pdf (last accessed March5, 2018)
-
- Schmid O, Jud C, Umehara Y, et al. . Biokinetics of aerosolized liposomal ciclosporin A in human lung cells in vitro using an air-liquid cell interface exposure system. J Aerosol Med Pulm Drug Deliv 2017:30;411–424 - PubMed
Publication types
LinkOut - more resources
Full Text Sources